Clinical Trials on High-risk Leukemias in New Zealand
Total 1873 results
-
New York City Health and Hospitals CorporationNew York State Department of HealthCompletedHigh-risk, High-cost Medicaid Services UsersUnited States
-
Schrödinger, Inc.RecruitingAcute Myeloid Leukemia | High-Risk and Very High-Risk Myelodysplastic SyndromesUnited States
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedHigh Risk Acute Myeloid LeukemiaUnited States, Canada
-
Magenta Medical Ltd.RecruitingHigh-risk Percutaneous Coronary InterventionUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHigh Risk for Postoperative Cardiovascular EventsUnited States
-
Abiomed Inc.CompletedPatients Undergoing High Risk PCI.United States, Netherlands
-
Abiomed Inc.Enrolling by invitationHigh-Risk Percutaneous Coronary InterventionUnited States
-
Queens College, The City University of New YorkState University of New York at BuffaloTerminatedParenting | Prevention | Child Maltreatment | Fathers | High-riskUnited States
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRecruitingCord Blood Transplant | High Risk Myeloid MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer Survivors | Statin Use Among High Risk SurvivorsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Pfizer; The Leukemia and Lymphoma SocietyTerminatedRefractory Acute Leukemia | Relapsed Acute Leukemia | High-Risk MyelodysplasiaUnited States
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicAustralia, United States, New Zealand
-
Dana-Farber Cancer InstituteActive, not recruitingRecurrent, Refractory, or High Risk Leukemias | Matched Targeted TherapyUnited States
-
Aptose Biosciences Inc.TerminatedAcute Myelogenous Leukemia | Acute Myelogenous Leukemia in Relapse | Acute Myelogenous Leukemia, Relapsed, Adult | Acute Myelogenous Leukemia, Adult | High Risk MyelodysplasiaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Adelphi University; Queen's Hospital CenterCompletedSurvey | Risk Perception | Cancer Related-Risks | Focus GroupUnited States
-
Opna-IO LLCCompletedHigh-risk Myelodysplastic Syndrome (MDS) | Relapsed Acute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML)United States
-
Memorial Sloan Kettering Cancer CenterTel-Aviv Sourasky Medical Center; Sheba Medical Center; Princess Alexandra Hospital...Active, not recruitingHigh-Risk Nevus PhenotypeUnited States
-
Northwell HealthTerminatedHigh Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime ExposureUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelomonocytic Leukemia-2United States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
University Hospital of CologneKarolinska Institutet; University Hospital of North Norway; Goethe University; McGill... and other collaboratorsUnknownPatients at High Risk of Antibacterial Treatment Upon AdmissionGermany
-
New York State Psychiatric InstituteTerminatedClinical High Risk for PsychosisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingClinical High Risk for Psychosis (CHR)United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingHigh Risk for Developing Breast CancerUnited States
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
Edwards LifesciencesTerminatedModerate to High-risk Noncardiac SurgeryUnited States
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Yale UniversityTerminatedClinical High Risk for PsychosisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
Yale UniversityCompleted
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingHigh Risk Esophageal VaricesIndia
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; The Cleveland Clinic; Vanderbilt University...Active, not recruitingThoracic Surgery | Atrial Fibrillation in High Risk PatientsUnited States
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Boston Scientific CorporationRecruitingHeart Disease, Coronary | High-risk Percutaneous Coronary InterventionUnited States, Sweden
-
Trigemina, IncCompletedHigh Frequency Episodic Migraine and Chronic MigraineChile, New Zealand, Australia
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
PDS Biotechnology Corp.CompletedHigh-risk HPV Infection and Biopsy-proven CIN1United States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruitingNeuroblastoma | High-RiskUnited States
-
Novartis PharmaceuticalsTerminated
-
Heinrich-Heine University, DuesseldorfAbiomed Inc.; Profil Clinical Trials Coordination GmbHRecruitingHigh-risk Percutaneous Coronary Intervention | Induced Acute Kidney InjuryGermany